Pharmaceutical / Pharmaceuticals / Drug / Drugs / National blog main / Wisconsin / Wisconsin blog main / Wisconsin top stories / Alpha-1 antitrypsin / Amgen / ARC-520 / ARC-521 / ARC-AAT / ARC-LPA / Arrowhead Pharmaceuticals / EX1 / Hepatitis B virus / Life Sciences

Arrowhead Shares Plunge Amid Layoffs, Canceled Liver Drug Programs

Posted on: Nov 30, 2016   |   Posted by: Biotech Mag

Arrowhead Shares Plunge Amid Layoffs, Canceled Liver Drug Programs

Arrowhead Pharmaceuticals said on Tuesday that it has canceled the development of three experimental drug candidates for liver diseases and plans to lay off part of its...

Continue reading ...